Characteristic | mFOLFIRINOX (n = 27) | Gemox (n = 22) | P value |
---|---|---|---|
Age | |||
 Median, range | 58 (41–73) | 56.5 (36–75) | 0.817 |
Sex | Â | Â | 0.181 |
 Male | 15 (55.6) | 8 (36.4) |  |
 Female | 12 (44.4) | 14 (63.6) |  |
ECOG | Â | Â | 0.407 |
 0 | 13 (48.1) | 8 (36.4) |  |
 1 | 14 (51.9) | 14 (63.6) |  |
Primary tumor sites | Â | Â | 0.434 |
 Intrahepatic | 16 (59.3) | 9 (40.9) |  |
 Hilar | 9 (33.3) | 11 (50.0) |  |
 Distal | 2 (7.4) | 2 (9.1) |  |
Disease status | Â | Â | 0.276 |
 Locally advanced | 6 (22.2) | 8 (36.4) |  |
 Metastatic | 21 (77.8) | 14 (63.6) |  |
Metastatic site | |||
 Liver | 17 (63.0) | 13 (59.1) | 0.782 |
 Lung | 5 (18.5) | 2 (9.1) | – |
 Bone | 1 (3.7) | 0 (0) | – |
 Other | 1 (3.7) | 1 (4.5) | – |
CA19–9 | |||
 Median, range | 172.0 (6.5–18,940) | 151.3 (1.7–26,666) | 0.680 |